KLDO (Kaleido Biosciences) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2021)


What is Kaleido Biosciences Other Stockholders Equity?

Kaleido Biosciences KLDO Other Stockholders Equity is $-0.00 Mil as of Dec. 2021.

Kaleido Biosciences's Other Stockholders Equity for the quarter that ended in Dec. 2021 was $-0.00 Mil.

Kaleido Biosciences's quarterly Other Stockholders Equity increased from Jun. 2021 ($-0.00 Mil) to Sep. 2021 ($0.00 Mil) but then declined from Sep. 2021 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil).

Kaleido Biosciences's annual Other Stockholders Equity declined from Dec. 2019 ($-0.00 Mil) to Dec. 2020 ($-0.00 Mil) but then increased from Dec. 2020 ($-0.00 Mil) to Dec. 2021 ($-0.00 Mil).

Kaleido Biosciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Other Stockholders Equity Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.00 -0.00 -0.00 -0.00

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 -0.00

Kaleido Biosciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Kaleido Biosciences (KLDO) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2021. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Other Stockholders Equity too high?
Kaleido Biosciences' current Other Stockholders Equity is $-0.00 Mil.
How does Kaleido Biosciences' Other Stockholders Equity compare to NPTX and GSTC?
Kaleido Biosciences' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.